JPRN-jRCT2080224180已完成1 期
Dialyzability and Pharmacokinetics of ASP2151 Following Single Oral Dosing in Hemodialysis Patients
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 9
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 80age old(—)
- 性别
- All
入选标准
- •Hemodialysis patients
排除标准
- •- Patients who have significant cardiac, hepatic, pulmonary, blood disease considered inappropriate for participation in clinical trials
- •- Patients with Hepatitis B virus, hepatitis C virus or HIV virus infection
- •- Patients who have an Hb value <9 g/dL at screening
- •- Patients with a history of gastrointestinal surgical operation
研究者
相似试验
已完成
不适用
Pharmacokinetics and Bioavailability of a New Oral Analgesic: Fentanyl Wafer ('Waferyl' (TM)), in Healthy Volunteers.Pain ManagementAnaesthesiology - Pain managementACTRN12611000106932iX Biopharma Pte Ltd24
招募中
不适用
euromuscular Blocking Effect of Rocuronium on Post-tetanic CountKCT0001283Inha University Hospital21
已完成
不适用
Pharmacokinetics and -dynamics of needlefree apomorphine administration vs. subcutaneous injections with apomorphine in patients with Parkinson*s disease; a pilot study with a new device10028037Parkinson's DiseaseNL-OMON35723niversitair Medisch Centrum Groningen10
进行中(未招募)
不适用
pharmacokinetic study by microdialysis of the distribution of ertapeneme and levofloxacine in infected foot ulcers of diabetics patients.EUCTR2007-001701-19-FRCHU DE POITIERS
进行中(未招募)
不适用
Pharmacokinectics of AP214 Acetate in patients undergoing cardiac surgery.A randomized, double-blind, placebo-controlled sequential ascending dose trialinvestigating pharmacokinetics, as well as safety, tolerability and pharmacodynamics of three dosing regimens of AP214 administered intravenouslyEUCTR2008-006968-11-DKAction Pharma A/S
